Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved

After a quarter century of work, the German biotech Immatics is facing a pivotal moment as it awaits Phase 3 results for its lead candidate in melanoma.

STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Wednesday 21 October →